Abstract: Mycetoma is a chronic suppurative disease of the skin and subcutaneous tissue, characterized by a symptomatic triad: tumor, fistulas and grains. It can be caused by fungi (eumycetoma) and bacteria (actinomycetoma), with similar clinical features. Diagnosis is based on the clinical presentation and identification of the etiological agents in the tissue, by mycological/bacteriological, histopathological and immunohistochemical tests. It is important to specify the fungal or bacterial etiology, because the treatments are different. An approach that involves early diagnosis, the use of systemic antibiotics or antifungal agents, including surgical removal of lesions, is the basis for the treatment of these diseases. In this review, the most commonly used diagnostic methods and treatments will be discussed. Also, we will review the history of the disease through epidemiological and etiological aspects.
INTRODUCTION
Mycetoma is a chronic suppurative infection of the skin and subcutaneous tissues that affects the lower limbs in more than 80% of cases. 1 The disease is characterized by a symptomatic triad: swelling of the affected area, multiple sinus formation, and a purulent discharge containing grains. [2] [3] [4] The grains represent microcolonies of the causative agent. The progression of the disease is slow and painless, but may affect deep structures such as muscles, tendons, joints, fascia and bones. The skin shows a wooden fibrotic induration due to dermal sclerosis. 3 Patients are otherwise in a good health condition with no satellite adenopathies. 2, 5 The etiologic agents of mycetoma are aerobic and anaerobic bacteria (actinomycetoma) and fungi (eumycetoma). In the tissue, these organisms are found in compact aggregates of filamentous bacterial colonies or fungal hyphae, which will characterize the grains. These structures are the fundamental elements of the disease. The bacteria are represented by delicate filaments of about 1μm or less, which are known as actinomycotic grains, while fungi are formed by thicker and coarser filaments, measuring 2μm or more in diameter, known as eumycotic grains. 4, 5, 7 Managing such infections is still challenging and treatment should involve early diagnosis, the use of antibiotics or systemic antifungals, and surgical removal of the lesions. 4, 8 In order to improve therapeutic results, healthcare professionals, especially dermatologists, must be aware of the epidemiology and clinical presentation of these infections.
HISTORY
The first reference to mycetoma dates from the Byzantine period (300-600 a.D.), with evidence from an adult skeleton whose morphological bone structure was suggestive of a mycetoma infection. 6, 7 However, the first written account of mycetoma was found in an ancient Indian religious book, Atharva Veda, where it was mentioned as "anthill foot". In 1842, Gill, a French missionary, described the first clinical cases of mycetoma in Madura, southern India, naming it "Madura foot". 3, 4, 6 In 1860, Carter used the term 'mycetoma', being the first to describe the disease under this name. 4, 6 In 1913, Pinoy observed that the disease was caused by two etiologic agents and divided the disease into two categories: actinomycetoma (bacterial agents) and eumycetoma (fungal agents). 6 The first attempt to map the distribution of mycetoma throughout the world was made by Abott in 1956. 6 He studied 1321 cases of mycetoma in Sudan during a period of two and half years. 3, 6 New studies were then carried out by other researchers in regions such as Congo, Somalia, Argentina and Mexico. 3, 6 EPIDEMIOLOGY Although mycetoma is found worldwide, it is endemic in tropical and subtropical countries, mostly between the latitudes 15 o south and 30 o north, known as the mycetoma belt.
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The countries with the highest incidence of the disease are Sudan, Venezuela, Mexico, and India, but Sudan and Mexico have the highest number of cases reported. 1, 3, 7, 8 Cases have also been reported in other African countries such as Egypt, Senegal, Mauritania, Kenia, Niger, Nigeria, Ethiopia, Chad, Cameroon, Djibouti, and Somalia. 3, 4, 6 In Latin America, besides Mexico which has the highest number of cases reported, the disease has also been registered in Venezuela, Colombia, Argentina, and Brazil. 3, 4 Other countries that have reported cases of mycetoma are the USA, Germany, the Netherlands, Turkey, Lebanon, Saudi Arabia, Iran, Philippines, Japan, Sri Lanka, and Thailand. 3, 4, 6 The endemic areas are characterized by short rainy seasons with little daily temperature fluctuations, followed by long dry sea- 3, 6, 7 The global incidence of actinomycetoma and eumycetoma varies from country to country and from region to region. Actinomycetoma is more prevalent in drier areas and eumycetoma in humid areas. 2, 3, 6 Actinomycetomas (bacterial agents) are more commonly found in South and Central America, whereas eumycetomas (fungal agents) are more common in Africa. Sudan is considered the most endemic country for mycetoma in the world. In Khartroum, capital of Sudan, more than 7000 patients have been treated for mycetoma and, in 70% of cases, the causative agent has been identified as the fungus Madurella mycetomatis. 1, 6 In Mexico and Brasil, actinomycetomas are more prevalent and Nocardia brasiliensis is the main etiologic agent. 1, 6 Some of the microorganisms that cause the disease are found in the soil and can enter the human body via a thorn prick, a wood splinter or a stone cut. 2, 3, 6 Mycetomas are considered occupational diseases of individuals who work in rural areas, such as farmers and shepherds, or that engage in activities related to the environment. 3, 6, 9, 10 Mycetomas can affect all age groups, but it occurs more commonly in young men aged between 20 and 40 years. 1, 2, 9 Men are more likely to be affected than women, with the male to female ratio ranging from 3:1 to 5:1.
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Environmental factors associated to genetic or immunologic predisposition can play a role in increasing the susceptibility to the disease.
1,2,10
Mycetoma has no known vector or animal reservoir. 4, 9, 14, 15 Once the fungus penetrates and inoculates in the subcutaneous tissue, it stays indolent until extending to deeper tissues and bones. Mycetoma can spread locally through the lymphatic system and, rarely, through the blood stream. Oral and facial mycetoma are uncommon.
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The typical clinical presentation is a painless subcutaneous mass of slow progression forming multiple sinuses that drain pus and clusters of bacterial and fungal structures called "grains". 4, 9 The host's inflammatory response consists of a neutrophilic infiltrate and the formation of granulomas that typically contain grains.
The clusters of fungal hyphae will vary in color according to the causative agent. 4, 9 Untreated infections will eventually destroy the tissues, including bones. The most frequent radiological finding in mycetoma is soft tissue swelling followed by bone sclerosis, bone cavities and periosteal reaction. 11, 16 After inoculation of the causative agent (fungi or bacteria) a subcutaneous infection develops. The is usually painless and processes slowly, over months and years. 4 In malnourished patients and patients with associated illnesses (e.g. malaria, HIV/AIDS, leishmaniasis, diabetes mellitus etc.) a more intense and faster progression of the disease may occur. 4, 7, 17 
DIAGNOSIS
The diagnosis of mycetoma is based on clinical presentation and identification of the etiologic agents. Clinical diagnosis is characterized by a symptomatic triad: a subcutaneous mass (tumefaction), draining sinuses and grain discharge. 1, 7, 17 The most specific diagnostic tool is the examination of the grains discharged from sinuses. Both spontaneous drainage and manually expressed material from sinus should be carefully examined macro and microscopically to visualize the grains. Table 1 .
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Culture is paramount to identify the causative organisms of mycetomas. The purulent discharge sampled should be centrifuged, sedimented and washed many times with saline to eliminate contaminants.
4,5,17
Colony growth should be checked daily and suspected colonies should be replicated in new media to promptly identify the etiologic agents. Eumycetoma grow slower than actinomycetoma, thus fungal cultures should be kept for up to six weeks before being discarded as negative. 5, 17, 19 Macroscopic and microscopic features of the most common etiologic agents found in Brazil are described below: 
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Nocardia asteroids grows well on Sabouraud agar, chocolate agar, and Czapeck-dox agar at 25-37 o C. Initially, the colonies have an elevated, glabrous, ridged, and granular surface; color is usually orange, but can range from yellow to pink. On Gram-stained smears, branched, delicate, and twisted filaments of 1μm are observed fragmenting into bacillary and coccoid structures.
On direct examination, Actinomadura madurae shows round or oval white-yellow grains that are insoluble in KOH 20% and ace- white-yellow that later become pink or red-raw.
Madurella grisea has black, oval or irregularly shaped grains that measure ≥ 1-2mm; growth is slow and may reach 17-25mm in diameter in 30 days at temperatures ranging between 26-30 o C.
Colonies are ridged and cerebriform with irregular and hardened edges; it has a grey to olive-green color that later becomes blackened with a velvety surface. The microculture of colonies shows septate and sterile mycelia measuring 1-3μm in diameter with rare chlamydospores and large moniliform hyphae (3-5μm). It grows well in Sabouraud agar and potato agar. Tables 1 and 2 show the morphologic and laboratory features of the etiologic agents more frequently isolated in mycetomas. 14 
HISTOPATHOLOGICAL DIAGNOSIS
Grains can be visualized with hematoxylin & eosin staining (H&E) and by special staining techniques, such as the Periodic-acid-Schiff (PAS) and Grocott-Gomori silver staining. Actinomycetoma should also be investigated using Gram staining. 4, 5 Histopathology shows granulomas of epithelioid cells and multiple giant cells. In the eumycetoma, the grains are characterized by clusters of branched hyphae radially arranged that occasionally forms vacuoles. Pink, sharp, large hyphae can be seen, surrounded In actionmycetoma, the delicate filaments are involved by an antigen-antibody complex forming an eosinophilic fringe (clubs), similar to the Splendore-Hoeppli phenomenon, that are found around the grains. 4, 5, 7 Histopathology is useful to confirm the clinical diagnosis and distinguish eumycetoma from actinomycetoma, but it does not identify the causative agent. 3, 7 Histological sections reveal a granuloma containing grains located in microabscesses.
5,7
MOLECULAR DIAGNOSIS
Recently, Molecular Biology techniques have become increasingly important in the identification of genera and species. 5 However, due to the lack of standardized techniques and the high cost, molecular diagnosis should be considered a complementary diagnostic tool and not a replacement for the conventional methods.
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RADIOLOGICAL IMAGING DIAGNOSIS Several imaging techniques can be used to determine the extent of lesions, including conventional X-rays, ultrasonography, magnetic resonance and computed tomography. 5, 7, 15 These radiological images are essential for surgical planning. TMP-SMX, other antibiotics were used, such as streptomycin, isoniazid, rifampicin and minocycline. 8, 22 Currently, the first-line treatment for actinomycetoma is amikacin (15mg/kg/day) during three weeks combined with TMP-SMX (40/8mg/kg/day) every 12 hours during five weeks. One to four 5-week cycles are recommended. Renal and audiometric monitoring is compulsory before, in between and after the cycles. It is important to perform sensitivity tests to antibiotics to confirm strand sensitivity, thus optimizing their use. 18 Eumycetoma is a neglected disease with few studies targeting its treatment, thus prospective clinical studies are needed to evaluate the therapeutic potential of the existing antifungals. 8, 17, 22 Itraconazole is the most commonly used drug for the treatment of eumycetoma. Its bioavailability is variable and absorption is related to stomach acidity and food intake. Existing reports indicate a favorable clinical response to its prolonged use, especially if followed by surgical excision. Fluconazole has also been reported as ineffective in the treatment of eumycetomas. 4, 8 New drugs belonging to the azole class have a broad spectrum, good bioavailability and low toxicity. In mycetoma, they are effective for the prolonged treatment of outpatients. However, there are limited studies in vitro and in vivo. Voriconazole and posaconazole
were assessed in a small number of patients with promising results.
Nonetheless, despite the good in vitro activity, prolonged treatment seems to be needed. Isavuconazole and fosravuconazole had excellent results in vitro, but no reports in vivo. Prospective studies are needed necessary to evaluate these antifungals. 4, 8 High-dose terbinafine (1000mg/day) for periods ranging from 24-48 weeks was effective against eumycetomas caused by Exophiala jeanselmei: 55% of patients showed a significant improvement while 25% were cured. However, terbinafine was not effective in deep infections due to S. apiospermum. 4, 8 There are no clinical data about the efficacy of echinocandins in eumycetomas. 4, 8 SURGICAL TREATMENT Surgical treatment is indicated both for small local lesions, and for massive compact lesions in order to reduce the mycetoma load and provide a better response to clinical therapy. 9, 19, 22 Antimicrobials should be used 3-6 months prior to surgery in order to form a fibrous capsule around the lesions, making surgical dissection and excision easier. Surgical intervention for mycetoma can cause morbidity, deformities and disabilities, particularly in the advanced stages of the disease. 8, 17, 20, 23 In general, bacterial mycetoma is likely to have good response rates to clinical treatment, in contrast to fungal mycetoma, that requires prolonged medical treatment and surgery. 8, 20 Radiological examination is important for surgical planning.
Ultrasound guided surgery can be useful to determine the precise location, size and the extension of the lesion.
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Careful surgical dissection, with safety margins, is necessary for an appropriate excision of the infected tissue, avoiding recurrence of the disease (Figure 4) . 17, 20, 23 Indications for surgery: the ground rule in our service is to treat all mycetoma surgically. Small, well defined lesions require fewer surgical interventions; however, in individuals that are not responding well to the clinical treatment, a greater number of surgical procedures is needed in order to reduce the dense, compact fungal load found in the lesions. Surgery can be a life-saving procedure in late stages of the disease, which can involve secondary bacterial infection, sepsis,and massive bone involvement. 1, 8, 20 Commonly, bones are studded with multiple cemented cavities containing grains and fibrous tissue. The debridement of the bone must be done carefully, removing grains and fibrous tissue from the cavities. 8, 20 In mycetoma, the infection usually spreads along the tissue levels forming deep pockets that are not easily detected. These pockets should be identified precisely to reduce post-operative recurrence. All damaged tissue must be debrided. 8, 20 After debridement, the surgical field should be thoroughly irrigated with saline to remove any grains that are left or infected tissue. Finally, the surgical field should be rinsed and irrigated methodically with iodine solution and hydrogen peroxide multiple times to remove and destroy hyphae and grains that have been left behind. 20 In large lesions, the wounds are left to secondary intention healing, with the formation of fibrous tissue, or are closed with a skin graft in a later stage, after the development of a good granulation tissue. 20 Early movement and physical therapy are compulsory for better surgical results, avoiding joint rigidity and reducing deformities and disabilities. 8, 20 The use of hydrogen peroxide on post-operative wounds is recommended. b) The symptomatic triad consists of a painless subcutaneous mass that progresses rapidly, forming sinuses that drain pus and grains.
c) The disease progresses similarly in immunocompetent and immunosuppressed patients.
d) The clinical presentation of actinomycetomas and eumycetomas are similar, however, their frequency depends on geographic location and climatic factors. bined to an IV carbapenemic 500mg every 8 hours for 3-6 months.
d) Amikacin 15mg/kg/day for 3 weeks combined with sulfamethoxazole-trimethoprim 40/8mg/kg/day for 5 weeks; 1-4 cycles.
Which of the statements regarding the surgical approach of mycetoma is correct:
a) It is the most efficient treatment and should be the first approach in actinomycetoma and eumycetoma.
b) Surgical dissection and resection should be performed after the use of an antimicrobial, allowing a fibrous capsule to form around the lesions.
c) Radiological tests are not important for surgical planning since mycetoma is not invasive and its limits are easily identified.
d) Neurological and orthopedic complications are inevitable since nerves and tendons are affected by the disease and need to be removed.
Regarding the epidemiological characteristics of mycetoma, it
is correct to state that: a) Men and women are equally affected since the disease affects young rural workers.
b) The disease is transmitted from person to person; it is common for family members living in the same area to present a similar clinical picture.
c) Mycetoma has a known reservoir. Etiologic agents are found in the soil. Rural workers in contact with wild animals are most susceptible to the disease.
d) The causative microorganisms are found in the soil; the infection starts with the inoculation through injuries on the skin.
Regarding the clinical features of mycetoma, it is correct to state that:
a) The evolution of the disease is painful and patient's overall health condition is compromised. Satellite adenopathies are observed.
b) The affected areas are indurated due to dermal sclerosis, compromising deep structures such as tendons and bones.
c) The purulent discharge containing grains eliminated from sinuses are the main elements for the diagnosis of mycetoma since pure colonies are always obtained from cultures. c) Grains are eliminated from sinuses, have variable size, color and texture and, although cultures are needed to accurately identify the causative agent, they can be used for a temporary identification.
d) The eosinophilic fringe resembling the Splendore-Hoeppli phenomenon is pathognomic in mycetoma. 
